Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
about
Current challenges and novel treatment strategies in double hit lymphomasMYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical managementNext-generation prognostic assessment for diffuse large B-cell lymphomaAllogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older PatientsEvolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent updateCentral nervous system prophylaxis in diffuse large B-cell lymphoma.Beyond RCHOP: A Blueprint for Diffuse Large B Cell Lymphoma Research.Double-Hit Lymphoma: Practicing in a Data-Limited Setting.Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.Management of Patients with MYC-Altered Lymphomas.Genetic lesions in diffuse large B-cell lymphomasCombination of BCL-2 and MYC protein expression improves high-risk stratification in diffuse large B-cell lymphoma.Establishment and characterization of a novel MYC/BCL2 "double-hit" diffuse large B cell lymphoma cell line, RCBCL-2 and MYC gain/amplification is correlated with central nervous system involvement in diffuse large B cell lymphoma at leukemic phase.Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma.Cutaneous presentation of Double Hit Lymphoma: A Case Report With Review of the Literature.Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era.Impact of oncogene rearrangement patterns on outcomes in patients with double-hit non-Hodgkin lymphoma.Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphomaOutcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704.PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications.Rituximab with dose-adjusted EPOCH as first-line treatment in patients with highly aggressive diffuse large B-cell lymphoma and autologous stem cell transplantation in selected patients.Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors.Emetine elicits apoptosis of intractable B-cell lymphoma cells with MYC rearrangement through inhibition of glycolytic metabolism.Overexpression of MYC and BCL2 Predicts Poor Prognosis in Patients with Extranodal NK/T-cell Lymphoma, Nasal Type.Recent progress: hematopoietic cell transplant for diffuse large B-cell lymphoma.A clinician's guide to double hit lymphomas.Relapsed or Refractory Double-Expressor and Double-Hit Lymphomas Have Inferior Progression-Free Survival After Autologous Stem-Cell Transplantation.Central nervous system prophylaxis in non-Hodgkin lymphoma: who, what, and when?Is now the time for molecular driven therapy for diffuse large B-cell lymphoma?Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.Frequency, Risk Factors, and Outcomes of Central Nervous System Relapse in Lymphoma Patients Treated with Dose-Adjusted EPOCH plus Rituximab.MYC gene rearrangement in diffuse large B-cell lymphoma does not confer a worse prognosis following dose-adjusted EPOCH-R.MYC Immunohistochemistry to Identify MYC-Driven B-Cell Lymphomas in Clinical Practice.B cells gone rogue: the intersection of diffuse large B cell lymphoma and autoimmune disease.Double hit lymphoma: from biology to therapeutic implications.Lymphoma classification update: B-cell non-Hodgkin lymphomas.Advances in the molecular diagnosis of diffuse large B-cell lymphoma in the era of precision medicine.High grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6: Double hit and triple hit lymphomas and double expressing lymphoma.Treatment approaches of hard-to-treat non-Hodgkin lymphomas.
P2860
Q26770385-F5F4D767-A886-46AA-9A64-9E1B1124B48FQ26785379-0134546E-2F1D-4AA2-BB76-3924D1B44FB1Q26796428-FCF8FC84-9C7C-48A4-BCEF-8936EC3C2E48Q28066710-3A1F459A-377A-4A98-8E1B-4FE4550D72AEQ28078869-AA50D7B6-2DE9-4670-BFB3-9AB187B698A2Q30251550-86FDE026-D44A-4CB7-A851-175C17A37FD0Q30275206-FEB29139-86CF-4331-8BCA-7F9135DD3F7AQ31056413-A29C486E-E2C4-4007-AB08-063DFDFF6E53Q33670880-9720A32C-F31A-4FC8-9087-E64A71DB7577Q35960027-EB081E5D-91B8-4958-B214-EA9BD5AA27F9Q35974341-AD92E691-E2F9-4C39-9624-72922B70A352Q36093288-5FF6CC3F-75B9-4947-9D9A-968EB4BBC73AQ36232304-89A4F946-D833-49F9-B8EE-04CF5D3E3C51Q36283342-4BCE1132-41FD-4EB8-8592-A559C88B1C95Q36771814-BBF41CB9-DEAA-4511-986F-0F90EB029B50Q36799405-8080906B-6F76-4984-8B07-EC0AA8713225Q37325037-E6A0E799-A27D-4C08-9611-BCCD19160E3EQ37347239-D5DC748A-F8C0-4FA6-A040-7567DEE11339Q37437423-961AFEB2-B722-45BD-92FC-2729781C3F7CQ37445933-EA7ACDEE-695C-4B60-87EE-21324EA7B3F1Q37644975-C782FD78-74AB-4189-AB80-20AC70CB1A1FQ37695075-B73318ED-575E-404B-AFB6-23B25BD9B6DCQ37696308-1C4155E9-C690-4CA8-BE6C-B1BCAA4197DCQ37706550-94A352CB-38B7-42C8-924A-45B4D42AFCF4Q37738081-C6719F16-49E3-4B49-B393-5755E94270F3Q38260183-B03149C4-8F22-4B34-9C27-3C7AB609FB8EQ38296091-745475FD-841F-44E1-95C6-25B92D3D2C12Q38376595-CD118670-B72F-4D51-A53C-AE8C65DDB996Q38441989-71EA7EF9-DDAC-4509-9223-CFD63537C7AFQ38656983-AB6C8C5D-7056-4388-816D-012CD9C8FA0FQ38663689-96EB1E33-32AB-4ACF-9AD5-DDA19F80DBEEQ38674040-9B760751-49F3-4517-985F-AC8B1B9938DFQ38713476-389C96A1-5CFE-4BF1-A877-8A46EAA4C2BBQ38719071-9FE42EB6-CB1A-46D1-9E2E-42567A0578B5Q38813104-17D7BFB4-A98B-435B-A2FD-E880DBDEB44DQ38831667-BBB36066-5B8A-4302-B64C-ACF887AEA49CQ38843988-B28515D9-30A9-40FC-9690-2EE810A79B52Q38959472-C8898894-CA4F-47CD-9FDE-CA441D2C20A6Q38975357-3F64EACF-C4C6-4E65-9768-1B0F30B8560AQ39091822-C0FA2704-9A8E-40B3-A98B-AA0E47899B3E
P2860
Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Impact of induction regimen an ...... center retrospective analysis.
@en
Impact of induction regimen an ...... center retrospective analysis.
@nl
type
label
Impact of induction regimen an ...... center retrospective analysis.
@en
Impact of induction regimen an ...... center retrospective analysis.
@nl
prefLabel
Impact of induction regimen an ...... center retrospective analysis.
@en
Impact of induction regimen an ...... center retrospective analysis.
@nl
P2093
P50
P1433
P1476
Impact of induction regimen an ...... icenter retrospective analysis
@en
P2093
Adam M Petrich
Aliyah R Sohani
Andrew D Zelenetz
Anthony Mato
Borko Jovanovic
Caitlin Handler
Camille Adeimy
Chadi Nabhan
Christina Howlett
Christopher R Flowers
P304
P356
10.1182/BLOOD-2014-05-578963
P407
P577
2014-08-26T00:00:00Z